|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-0.48/-0.69
|
企業價值
84.05M
|
資產負債 |
每股賬面淨值
1.06
|
現金流量 |
現金流量率
--
|
損益表 |
收益
20.13M
|
每股收益
0.16
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/19 00:36 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies. |